J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.

Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement for individuals with BPH ...

A new paper evaluating Neuromod’s tinnitus treatment has found that 91.5% of patients saw reductions after 12 weeks of ...

Abbott has reported new data from its Volt CE Mark Study in individuals treated with PFA therapy using the Volt PFA System ...

The US FDA has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ...

Kardium has revealed positive one-year efficacy results on its pulsed field ablation (PFA) device, the Globe PF System.

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

Contraception for women has seen little change over the past 50 years, with the most prevalent contraceptive pills containing ...

Boston Scientific reports positive outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse and Farapoint ...

The GHIT Fund has awarded a grant of ~$4.5m to Fluxus for developing an ultrasensitive point-of-care (POC) urine test for ...

Roche reported flat Q1 sales for its diagnostic division, citing headwinds in China, but reaffirmed the market’s strategic ...

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...